KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis.

Cite this paper

@article{Mao2013KRASPM, title={KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis.}, author={Chen Mao and Ya-fang Huang and Zuyao Yang and Da-yong Zheng and Jin-zhang Chen and Jin-Ling Tang}, journal={Cancer}, year={2013}, volume={119 4}, pages={714-21} }